Biotechnology Analysis & Statistics, November 2014 (p10)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Publishers

All regions

271-300 of about 2 400 reports

Purchase Reports From Reputable Market Research Publishers

GENova Biotherapeutics, Inc. (Symbol:GVBP) SWOT Analysis, Strategy, Revenues and Profits

GENova Biotherapeutics, Inc. (Symbol:GVBP) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : United States
Helicos BioSciences Corporation (Symbol:HLCS) SWOT Analysis, Strategy, Revenues and Profits

Helicos BioSciences Corporation (Symbol:HLCS) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Genomics
  • Countries : United States
Genitope Corporation (GTOP) - Strategic SWOT Analysis Review

Genitope Corporation (GTOP) - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Genitope Corporation (Genitope) is a publicly held US based biotechnology company. It is focused on the research and development (R&D) of novel immunotherapies for the treatment of cancer. The ...

  • Industries : Biological Therapy
  • Countries : United States
Huifeng BioPharmaceutical Technology Inc. (Symbol:HFGB) SWOT Analysis, Strategy, Revenues and Profits

Huifeng BioPharmaceutical Technology Inc. (Symbol:HFGB) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : China
Igene Biotechnology, Inc. (Symbol:IGNE) SWOT Analysis, Strategy, Revenues and Profits

Igene Biotechnology, Inc. (Symbol:IGNE) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biotechnology
  • Countries : United States
IntegraGen S.A (Symbol:ALINT) SWOT Analysis, Strategy, Revenues and Profits

IntegraGen S.A (Symbol:ALINT) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Genomics
  • Countries : France
Molecular Imaging Corporation SWOT Analysis, Strategy, Revenues and Profits

Molecular Imaging Corporation SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Genomics
  • Countries : United States
MP Biomedicals, LLC SWOT Analysis, Strategy, Revenues and Profits

MP Biomedicals, LLC SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States
Nkbio Co., Ltd. (Symbol:019260) SWOT Analysis, Strategy, Revenues and Profits

Nkbio Co., Ltd. (Symbol:019260) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : South Korea
Nova Biomedical Corporation SWOT Analysis, Strategy, Revenues and Profits

Nova Biomedical Corporation SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States
Omnimmune Holdings, Inc. (Symbol:OMMH) SWOT Analysis, Strategy, Revenues and Profits

Omnimmune Holdings, Inc. (Symbol:OMMH) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States
Optimer Pharmaceuticals, Inc. (Symbol:OPTR) SWOT Analysis, Strategy, Revenues and Profits

Optimer Pharmaceuticals, Inc. (Symbol:OPTR) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : United States
Pall Biomedical Inc SWOT Analysis, Strategy, Revenues and Profits

Pall Biomedical Inc SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States
PCI Biotech AS (Symbol:PCIB) SWOT Analysis, Strategy, Revenues and Profits

PCI Biotech AS (Symbol:PCIB) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biotechnology
  • Countries : Norway
MWG-Biotech AG - Strategic SWOT Analysis Review

MWG-Biotech AG - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary MWG-Biotech AG (MWG) is a biotechnology company. The company manufactures and markets biomolecules and apparatus for use in molecular biology. Its products include PCR primer, cloning oligo, qPCR ...

  • Industries : Genomics
  • Countries : Germany
Pressure BioSciences, Inc. (Symbol:PBIO) SWOT Analysis, Strategy, Revenues and Profits

Pressure BioSciences, Inc. (Symbol:PBIO) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Genomics
  • Countries : United States
Puleva Biotech S.A. (Symbol:BIO) SWOT Analysis, Strategy, Revenues and Profits

Puleva Biotech S.A. (Symbol:BIO) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biotechnology
QuantRx Biomedical Corporation (Symbol:QTXB) SWOT Analysis, Strategy, Revenues and Profits

QuantRx Biomedical Corporation (Symbol:QTXB) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States
ReGenX Biosciences, LLC SWOT Analysis, Strategy, Revenues and Profits

ReGenX Biosciences, LLC SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : United States
Schnell Biopharmaceuticals, Inc. (Symbol:003060) SWOT Analysis, Strategy, Revenues and Profits

Schnell Biopharmaceuticals, Inc. (Symbol:003060) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : South Korea
SemBiosys Genetics Inc. (Symbol:SBS) SWOT Analysis, Strategy, Revenues and Profits

SemBiosys Genetics Inc. (Symbol:SBS) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Genomics
  • Countries : Canada
TranXenoGen, Inc. SWOT Analysis, Strategy, Revenues and Profits

TranXenoGen, Inc. SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biotechnology
  • Countries : United States
Verenium Corporation (Symbol:VRNM) SWOT Analysis, Strategy, Revenues and Profits

Verenium Corporation (Symbol:VRNM) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States
Viropro Inc. (Symbol:VPRO) SWOT Analysis, Strategy, Revenues and Profits

Viropro Inc. (Symbol:VPRO) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : United States
Ventana Biotech Inc. - Strategic SWOT Analysis Review

Ventana Biotech Inc. - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Ventana Biotech Inc. (Ventana Biotech) is a bioscience company that is engaged in the development and marketing of products for the metabolic disorders. It focuses in the areas of anti-obesity ...

  • Industries : Biotechnology
  • Countries : United States
Zhejiang Qianjiang Biochemical Co Ltd (Symbol:600796) SWOT Analysis, Strategy, Revenues and Profits

Zhejiang Qianjiang Biochemical Co Ltd (Symbol:600796) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biotechnology, Pesticide
  • Countries : China
Cheil Bio Co., Ltd. (Symbol:052670) SWOT Analysis, Strategy, Revenues and Profits

Cheil Bio Co., Ltd. (Symbol:052670) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biotechnology
  • Countries : South Korea
Chemokine Therapeutics Corp. (CTI) - Strategic SWOT Analysis Review

Chemokine Therapeutics Corp. (CTI) - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Chemokine Therapeutics Corp. (Chemokine Therapeutics) is a publicly held biotechnology company. It is engaged in the discovery and develops peptide analogs of chemokines for cancer treatment and ...

  • Industries : Biological Therapy
  • Countries : Canada, United Kingdom
Eternal Technologies Group, Inc. (ETLT) - Strategic SWOT Analysis Review

Eternal Technologies Group, Inc. (ETLT) - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Eternal Technologies Group, Inc. (Eternal Technologies) is an agricultural genetics company, engaged in industrialized animal-embryo production to produce hardier flocks. It has been producing ...

  • Industries : Livestock, Biotechnology
  • Countries : China
DelSite Biotechnologies, Inc. (Symbol:DSII) SWOT Analysis, Strategy, Revenues and Profits

DelSite Biotechnologies, Inc. (Symbol:DSII) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biotechnology

About 100 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Johnson and Johnson

United States

Life Technologies Corp.

United States

Illumina Inc.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.